Nucleotide excision repair is the principal way by which human cells remove UV damage from DNA. Human cell extracts were fractionated to locate active components, including xeroderma pigmentosum (XP) and ERCC factors. The incision reaction was then reconstituted with the purified proteins RPA, XPA, TFIIH (containing XPB and XPD), XPC, UV-DDB, XPG, partially purified ERCCl/XPF complex, and a factor designated IF7. UV-DDB (related to XPE protein) stimulated repair but was not essential. ERCC1-and XPFcorrecting activity copurified with an ERCCl-binding polypeptide of 110 kDa that was absent in XP-F cell extract. Complete repair synthesis was achieved by combining these factors with DNA polymerase ~, RFC, PCNA, and DNA ligase I. The reconstituted core reaction requires about 30 polypeptides.
Introduction
Nucleotide excision repair (NER) is a major pathway by which a large variety of DNA damage is eliminated from the genome. This DNA repair pathway processes damage by locating the lesion, excising an oligomer carrying the damaged nucleotides, and synthesizing a repair patch, using the opposite strand as a template (Sancar and Tang, 1993; Aboussekhra and Wood, 1994) .
The NER mechanism is well understood in Escherichia coli, in which six proteins, UvrA, UvrB, UvrC, UvrD, polymerase I (pol I), and Lig are necessary and sufficient to carry out this process in vitro (Sancar and Tang, 1993) . In eukaryotic cells, less is known about the biochemistry of the N ER process, and the reaction is of greater complexity. The best-characterized components are the xeroderma pigmentosum (XP) factors, which correct the DNA repair deficiency of the seven complementation groups of XP cells, XP-A to XP-G. XP proteins are thought to be required for the first steps of the excision repair process. XPA is a DNA damage-binding protein, XPC is a single-stranded DNA-binding protein, and XPG is an endonuclease (Aboussekhra and Wood, 1994; O'Donovan et al., 1994a; Hoeijmakers, 1993) . Two DNA helicases, XPB and XPD, are also involved as components of the transcription factor TFIIH. The whole TFIIH complex seems to participate in transcription and NER Drapkin et al., 1994; Schaeffer et al., 1994) . ERCC1 (for excision repair cross-complementing), a product of a human gene that corrects the defect in rodent cells of repair complementation group 1, is also required. ERCC1 is the human homolog of Saccharomyces cerevisiae RAD10 and of Schizosaccharomyces pombe swil0. RAD10 associates with RAD1 in S. cerevisiae to form an endonuclease (Bardwell et al., 1994) , and swil0 associates with rad16 in S. pombe, where it is expected to form an analogous endonuclease (Carr et al., 1994) . Similarly, mammalian ERCC1 is known to associate in a tight complex with (at least) XPF and ERCC4 complementing activities (van Vuuren et al., 1993; Biggerstaff et al., 1993) . It is likely but not proven that ERCC4 and XPF are the same protein and are homologous to RAD1 and rad16. By analogy with yeast, the mammalian complex is expected to have a role as a second endonuclease during NER; we henceforth refer to it as the ERCC1/XPF complex.
Of emerging importance in understanding the mechanism of NER in mammalian cells is biochemical fractionation of the process carried out by cell-free extracts in vitro (Wood et al., 1988; Wood et al., 1993) . This approach has already resulted in the identification of factors involved in DNA repair in addition to the XP and ERCC proteins. These factors include replication protein A (RPA) and proliferating cell nuclear antigen (PCNA) (Coverley et al., 1992; Shivji et al., 1992; Nichols and Sancar, 1992) , previously found by fractionating the components needed for replication of SV40 viral DNA.
Although most of these known factors have been purified and their corresponding genes cloned, their precise functions and their interactions with one another during the repair process are still unclear. To identify novel proteins involved in NER and to characterize the mechanism of action of the known ones, it is necessary to undertake a reconstitution of the NER reaction in vitro with purified components. Similar approaches have been very productive for studying DNA replication and transcription in mammalian cells. For this purpose, human HeLa cell extract has been divided into multiple fractions that have been used to reconstitute repair, and these have subsequently been replaced by purified factors.
The results presented here show that purified mammalian NER proteins are able in vitro to fulfill with high specificity the complete NER reaction and show the requirement of a novel factor called IF7 for this process.
Results

Fractionation of HeLa Cell Extract and Reconstitution of NER Synthesis
To separate the NER factors from one another, whole-cell extract from HeLa cells was divided by phosphocellulose column chromatography into four fractions, designated FI, FII, Fill, and FIV (Figure 1 ). These fractions were mixed in different combinations with ultraviolet (UV)-irradiated and nonirradiated DNA in the presence of [a-32P]dATP and ATP to reconstitute the NER process in vitro (Figure 2A) . A combination of fractions I, II, and III was able to perform repair synthesis in the damaged DNA ( Figure 2A , lane 1), and each of these fractions was required ( Figure 2A , lanes 5, 6, and 7). FIV was not required for the reaction ( Figure  2A , lane 1, versus lanes 2, 3, and 4).
It has been shown previously that FI contains RPA and PCNA proteins, essential for NER in vitro (Shivji et al., 1992) . Purified RPA and PCNA in combination with FII and Fill gave a level of specific repair synthesis similar to that obtained with FI plus FII plus Fill (compare lanes 1 and 11), showing that FI could be replaced by these two factors.
Our experience with purifying different DNA repair proteins indicated that many known factors required for NER were present in fraction II. Therefore, FII was further divided by hydroxyapatite chromatography into four components (see Figure 1 ). Proteins eluted with 20, 60,200, and 500 mM phosphate were designated fractions Ila, lib, tic, and lid, respectively. Addition of these four fractions to fractions FI and Fill resulted in specific repair synthesis ( Figure 2B , lane 5), identical to that obtained by combining FI, FII, and Fill (lane 9) . In the presence of sufficient amounts of fractions Ila, lib, and lid, fraction IIc was not required (lane 4). fraction lid was required in the absence of fraction IIc (compare lanes 2 and 4). Significant repair could occur in the absence of fraction Ila (lane 8).
Use of UV-DDB/XPE Factor in Place of Fraction Ila
XP-E cells are only slightly sensitive to the killing effect of UV light (Cleaver and Kraemer, 1989) . Cells from two consanguineous XP-E patients are deficient in a DNAbinding activity that recognizes UV-irradiated DNA (UV-DDB) (Chu and Chang, 1988; Hirschfeld et al., 1990; Kataoka and Fujiwara, 1991; Keeney et al., 1992) . A polyclonal antibody recognizing the primate UV-DDB p127 (Takao et al., 1993) cross-reacted with a factor with the same molecular mass in fraction Ila, but not in lib, IIc, or lid, demonstrating the presence of UV-DDB/XPE factor in this fraction (data not shown). Addition of purified UV-DDB factor to a mixture containing RPA, PCNA, and fractions lib, lid, and III led to about a 2-fold stimulation of repair synthesis, to a level similar to that allowed by inclusion of fraction Ila ( Figure 3A ). These results indicated that the UV-DDB/XPE factor can replace fraction Ila and suggested that the factor plays an accessory but not a core role in the NER process.
Substitution of Fraction lid by Pure Recombinant XPG Protein
XPG protein is essential for the catalysis of the incision 3' to damage during NER (O'Donovan et al., 1994a) . The known chromatographic behavior of XPG was consistent with its presence in hydroxyapatite fraction lid (O'Donovan et al., 1994b) , and this was the only XP complementing activity that we could detect in this fraction. Indeed, purified XPG protein could substitute for fraction lid in the reconstitution reaction. When RPA, PCNA, UV-DDB, and fractions lib and III were mixed in a DNA repair reaction, only extremely low repair activity was detected, reflecting the absence of at least one essential excision repair factor ( Figure 3B , lane 1). Inclusion of pure recombinant XPG protein (lanes 2 and 3) resulted in specific excision repair synthesis similar to that achieved by addition of fraction lid ( Figure 3B , lane 4), indicating that the only essential NER factor in this fraction was XPG. Thus, the full NER reaction could be carried out with four purified factors (RPA, PCNA, UV-DDB, and XPG) and two crude fractions (lib and III).
Use of Exonuclease-Free DNA Pol I in a Coupled Incision/Synthesis Repair Reaction
The NER reaction consists broadly of two stages, generation of excised intermediates and gap-tiffing DNA synthesis. To dissect the system further, we needed a sensitive assay avoiding the use of the mammalian DNA replication machinery during the second stage. Exonuclease.free ow-through Figure 5 . Properties of ERCCI/XPF Complex (A) Activity of ERCCI/XPF complex during purification. Top, the CMSepharose fraction was purified on an FPLC Mono Q column as step 6 of the purification. From each of the indicated fractions, 10 pJ was then assayed for the ability to complement 100 ~g of CFII fraction from CHO 43-3B cells (ERCC1-). Minus, no Mono Q fraction added; MFT, 10 Id of the column flowthrough was assayed; CM, 10 p_l of the column load was assayed. Bottom, assay after step 7 (FPLC Mono S chromatography) of the ERCC1 complex. Results of a repair assay with CFII fractions are shown, with an autoradiograph and photograph of an ethidium bromide-stained gel for comparison. The sources and amounts of recipient extract protein (CFII fraction) were as follows: ERCC1 , 100 I~g from CHO 43-3B; ERCC4-, 70 ~g from CHO UV41; XP-F, 70 I~g from GM8437; ERCC3-, 100 I~g from CHO 27-1. The assays had either no addition (minus); 10 p_l of purified ERCC1 complex, Mono S fraction 62 (mS); 10 Id of the Mono Q flowthrough (MFT); or a mixture of 50 I~g of ERCC1-and 50 I~g of ERCC3-CFII protein as a positive control (x3). (B) ERCCl-binding polypeptide in cell extracts and its absence in XP-F extracts (top); reduction of ERCC1 in XP-F extract (bottom). Whole-cell extracts from cells of the indicated XP groups A to F were assayed for binding to ERCC1 by protein blotting in the top panel and for ERCC1 polypeptide by immunoblotting in the bottom panel. In the last lane, protein was assayed from step 4 of the ERCC1 complex purification (AcA34 gel filtration). (C) Presence of ERCC1 and an ERCCl-binding polypeptide at step 7 of ERCCI/XPF complex purification. The indicated fractions from the Mono S column were assayed for binding to ERCC1 by protein blotting (top) and by immunoblotting with anti-ERCC1 antibody (bottom).
purpose. UV-irradiated and nonirradiated plasmids were incubated with RPA and fractions FII and Fill in the absence of PCNA to allow accumulation of gapped excision repair intermediates in damaged plasmids (Shivji et al., 1992; Nichols and Sancar, 1992) . Exo-free pol I and [a-3=P]dATP were then added and incubation continued. Without PCNA or the exo-free pol I, only a very low damage-dependent labeling was detected ( Figure 3C, lane 1) . Addition of either PCNA to activate the human DNA replication machinery or the exo-free pol I resulted in quantitatively similar damage-dependent labeling (compare Figure  3C , lanes 2 and 3). Reactions using plasmids containing a single lesion further showed that the patch produced by exo-free pol I during the NER reaction was about 30 nt long, similar to that made by the human system (data not shown). Exo-free pol I was then used in the next series of experiments to monitor incised DNA created during repair.
NER with Purified Human Factors and Exo-Free Pol I
Additional purified components were employed to replace the undefined fractions lib and Fill used in Figure 3 . Complementation experiments indicated that most XPC activity was present in fraction Fill (Shivji et al., 1994) , most XPA activity was in fraction FII , and XPB and XPD complementing activities were split between FII and Fill, consistent with the purification properties of TFIIH (Flores et al., 1992) . XPA, XPG, XPC, and TFIIH were all available in highly purified form, either from HeLa cells or as recombinant proteins (Figure 4) . ERCC1, ERCC4, and XPF in vitro complementing activities were also located in fraction lib. ERCC1 was available as a recombinant protein , but it has little or no activity on its own, because ERCC1 forms a protein complex in the cell with the XPF protein. The complex is believed to function as a nuclease that catalyzes the 5' incision during repair (Bardwell et al., 1994; O'Donovan et al., 1994a) . Recombinant ERCC4/XPF could not be produced, since the gene sequences have not been reported, and so the complex was purified further according to the scheme in Figure 4 . At each step, ERCC1 polypeptide was followed by immunoblotting and by group 1 complementing activity. The purified ERCC1 complex (step 7, fast protein liquid chromatography [FPLC] Mono S fractionation) could correct the defects in XP-F cell extracts as well as rodent group 1 and group 4 extracts (Figure 5A) .
At step 7, the preparation consisted of about 30 polypeptides detectable by silver staining (see Figure 4) , and one of these comigrated with ERCC1 as determined by immunoblotting ( Figure 5 ). To define further the composition of the ERCC1 complex, we sought a protein that bound tightly to ERCC1. Whole-cell extract protein from different XP cell extracts was separated by SDS-polyacrylamide gel electrophoresis (PAGE) and transferred to a membrane by electroblotting. Recombinant His-tagged ERCC1, labeled with 1251, was then used to probe the membrane in renaturing buffer. Under appropriate conditions, several major bands were detected in crude extracts. The band were added, and the reaction was further incubated for 10 rain. DNA was purified end separated without restriction enzyme treatment on an agarose gel containing ethidium bromide (top). The autoradiograph (bottom) shows repair synthesis in the nicked circular DNA. The closed circular DNA was relaxed by a topoisomerase activity present in the partially pu rifled E RCC I/XPF complex at step 5 (CM). In the absence of step 5 ERCC1 complex, the closed circular DNA remained supercoiled (lane 5), while nicked plasmids and the small fraction of linear plasmids were highly labeled. (B) DNA and proteins were incubated together as in (A). ERCC1 complex (4 ILl) was added as indicated, either purified through step 5 (CM), step 6 (mQ), or step 7 (mS). The fraction MFT (600 ng of protein) was added where indicated (plus). DNA was purified and separated on an agarose gel containing ethidium bromide. The autoradiography shows repair synthesis, which took place only in the nicked DNA forms shown.
of greatest interest migrated with a relative molecular mass of about 110 kDa and is tentatively identified as the XPF protein, because it is specifically absent in XP-F cell extracts ( Figure 5B ). As previously reported, the level of ERCC1 was also much reduced in XP-F extracts ( Figure  5B ), presumably because it is unstable in the absence of its partner . Similar membranes were probed after electrophoresis of fractions from the ERCC1 complex purification, and this band was found in the active fractions. At step 7 of the ERCC1/XPF complex purification, the 110 kDa polypeptide was the only ERCC1-binding band detectable ( Figure 5C ). The molecular mass of this protein is consistent with the size predicted from studies of yeast, since the ERCC1 homologs S. cerevisiae RAD10 and S. pombe swil0 form complexes with the 120 kDa RAD1 and the 106 kDa red16 proteins, respectively (see Carr et al. [1994] ). The most active fractions from the Mono S column were numbers 61 and 62, and these also contained the ERCC1 polypeptide ( Figure 5C ); fraction 63 contained 5-to 10-fold less ERCC1 (data not shown). The active ERCCl-containing complex at step 7 might consist of only the 31 kDa ERCC1 protein and the 110 kDa XPF protein, since the molecular weight of the complex from cruder fractions was estimated by hydrodynamic methods to be -100-120 kDa in size van Vuuren et el., 1993) . Highly purified RPA, XPA, XPC, XPG, TFIIH complex, UV-DDB, and partially purified ERCC1 complex (CMSepharose, step 5) were used in conjunction with exo-free pol I. Lane 1 of Figure 6A shows that this combination of factors was able to carry out NER synthesis. Labeling was present only in the nicked form of irradiated DNA because of the absence of a ligase activity in the reaction. Systematic omission of each factor from the repair reaction showed that RPA, XPA, XPC, TFIIH, and XPG were essential for the NER reaction ( Figure 6A, lanes 2, 4, 6 , 7, and 8). UV-DDB was not essential for this core reaction ( Figure  6A, lane 3) .
Omission of the ERCCI/XPF complex (CM-Sepharose; fraction 5) gave, unexpectedly, synthesis in both damaged and nondamaged DNA ( Figure 6A , lane 5). Such indiscriminate synthesis is diagnostic of strand displacement synthesis by exo-free pol I, initiated at a low nu tuber of random nicks in the plasmid circles. This indicated that some component present at step 5 (CM-Sepharose) of the ERCC1 complex purification was able to suppress the uncontrolled behavior of the exo-free pol I. The high nonspecific labeling also occurred when a more purified ERCCI/XPF complex (Mono S, step 7) was used ( Figure 6B, lane 2) , showing that the additional factor required for specificity of repair synthesis with exo.free pol I could be separated from the ERCCI/XPF complex. Further experiments localized this factor in the flowthrough fraction (designated M FT) from the Mono Q column du ring step 6 of the ERCC 1/ XPF purification. The addition of the MFT fraction to repair reactions containing more purified ERCCI/XPF complex (Mono Q or Mono S fractions) led to repair synthesis preferentially in damaged DNA ( Figure 6B, lanes 3 and 4) . As in Figure 6A , the reaction was completely dependent not only on ERCCI/XPF complex ( Figure 6B , lane 5) but also on the other repair factors, including TFIIH ( Figure 6B , lane 6). The novel factor in the MFT fraction that is needed for reconstitution of the NER process is tentatively designated incision factor 7 (IF7).
Reconstitution of the Complete NER Process with Purified Mammalian Proteins
The above experiments determined the human proteins and fractions required to initiate incision and create substrates that could be acted on by E. coil DNA polymerase. Next, purified mammalian proteins involved in DNA repair and replication were used to carry out the gap-filling synthesis and ligation steps to complete the NER reaction. For this purpose, DNA pol ~ was used, together with RPA, DNA ligase I, and the polymerase accessory factors replication factor C (RFC) and PCNA. Experiments to be described elsewhere (M. K. K. S., V. N. P., U. H., and R. D. W., unpublished data) show that this combination of proteins is well suited to fill gaps produced during repair. The NER reaction was first reconstituted in two stages. During the first stage, the damaged and nondamaged DNA was incubated for 60 min with the mixture of incision proteins described for Figure 6 , but without polymerase. The DNA was then purified and incubated with the gapfilling and ligation proteins, in the presence of dNTPs and [~-32P]dATP. Specific repair labeling occurred when the CM-Sepharose fraction containing ERCC1/XPF complex was used ( Figure 7A , lane 1). When Mono Q or Mono S fractions were used, no repair synthesis was detected ( Figure 7B, lanes 1 and 2) , indicating the requirement for an additional DNA repair factor, as shown above by use of the exo-free pol I. Addition of fraction MFT during the first stage of the reaction allowed reconstit ution of the complete repair process ( Figure 7A and B, lanes 3) . Repair synthesis specific for UV-irradiated DNA required the ERCCI/XPF complex ( Figure 7B, lanes 3 and 4) , as well as the other added components.
The next step was to carry out reconstitution experiments with all the proteins required for excision repair added together in the same reaction mixture. Such reactions were successful ( Figure 7C, lane 1) , but the proportion of final repair product converted to the closed circular form was lower than in the two-stage reactions. Omission of any of the incision/excision components prevented damage-dependent repair, as shown for TFIIH ( Figure 7C , lane 2) and XPG (lane 3). In an attempt to increase the proportion of ligated products, the 5'-3' exonuclease DNase IV was included in some reactions, but it had no effect (data not shown). DNase IV (Robins et al., 1994) , also known by other names, such as factor pL and MF-1, increases the proportion of ligated products during lagging strand synthesis of SV40 DNA in vitro (Ishimi et al., 1988; Waga et al., 1994) . To some extent, the repair and replication factors may interfere with each other, giving lesscompleted products when all act together at once in vitro ( Figure 7C ) than when the reaction is performed in two stages ( Figures 7A and 7B) . A small amount of 5'-phosphatase activity as a contaminant of one of the factors might also cause the reduction in the ligated fraction. Nevertheless, the defined factors are able to carry out the complete reaction to form some fully repaired products.
Discussion
Components of the Incision/Excision Reaction
To dissect the mechanism of NER and characterize further the proteins required, the complete NER reaction was reconstituted in vitro by use of purified mammalian factors. To ensure that previously uncharacterized NER factors would be detected, the process was first reconstituted by using HeLa cell extract fractions, and these were then replaced by purified components. A number of new conclusions can be reached on the basis of this study.
To analyze the NER process in two stages, we initially made use of a bacterial DNA polymerase to incorporate radioactive deoxynucleotide monophosphates (dNMPs) after creation of incisions by human proteins rather than requiring that all of the purified human DNA replication machinery be present at each step. The repair synthesis performed by exo-free DNA pol I was DNA damagedependent and gave a normally sized repair patch (see also Calsou and Salles [1994] ). This indicates that either the excision gap was relatively free of human proteins under these in vitro conditions or that the DNA polymerase had access to the 3"OH end of the gap and was able to carry out repair synthesis even in the presence of human DNA repair proteins.
One fraction, M FT, was first identified by its requirement for conferring specificity in the pol I repair synthesis assay. This fraction also proved to be essential for creating incised structures that could be acted on by the mammalian repair complex and so contains at least one previously unknown factor required for NER. This novel factor (IF7) is only partially purified and requires further characterization. Genetic studies suggest several possibilities for the identity of IF7, including the human counterparts of S. cerevisiae RAD7 and RAD16 (Hoeijmakers, 1993) , or the products of uncloned genes complementing rodent repair groups 7 through 11 . One or more of these may be core repair factors, while others are likely to be modulating accessory factors.
Highly purified RPA, XPA, XPG, XPC, TFIIH complex, partially purified ERCCI/XPF complex, and IF7 factor were essential and sufficient for the reconstitution of the first stage of the NER reaction. Thus, as anticipated from studies of intact cells (Cleaver and Kraemer, 1989) , all of these XP factors act at the incision stage of repair. It is also important to note that, as previously indicated (Coverley et al., 1992; Shivji et al., 1992) , the single-stranded DNAbinding protein RPA is also required during the first stage of the repair reaction. As shown in Figure 6A , there was a reduced proportion of nicked damaged molecules when RPA was absent, and only very low labeling by polymerase. This strongly suggests that RPA has a role either in recognizing DNA damage (Clugston et al., 1992) or in forming part of the active incision complex. The known and predicted nuclease activities of XPG and the ERCCI/ XPF complex are ideally suited for cleaving near the junction of duplex DNA and an open structure created by the recognition/incision complex (Bardwell et al., 1994; O'Donovan et al., 1994a) . RPA could be involved in creating or stabilizing this open structure by binding to singlestranded DNA created by the helicase activity of TFIIH. Indeed, the binding site size of a molecule of human RPA on single-stranded DNA is -20-30 nt (Kim et al., 1992; Seroussi and Lavi, 1993) , which corresponds well with the distance between the two incisions in UV-irradiated DNA (Huang et al., 1992) .
In one recent study, TFIIH purified by a different method than that used here was found to copurify through several steps with XP-C complementing activity (Drapkin et al., 1994) . With the purification scheme used here, both purified XPC and purified TFIIH complex were required to reconstitute the repair reaction. Omission of either factor gave reaction mixtures with no significant activity. Thus, our highly purified TFiIH preparation does not contain XPC complementing factor. The XPC protein complex binds tightly to single-stranded DNA and is approximately the same size as RPA (Masutani et al., 1994; Shivji et al., 1994) , and so it might also bind to an opened DNA structure during incision.
The UV-DDB/XPE factor appears to have an accessory role in the NER reaction by stimulating repair of UVirradiated DNA, but is not necessary for the core process. Individuals with group E xeroderma pigmentosum have a mild form of the disorder, and repair in vivo is usually -50°/0 of normal. The 127 kDa subunit of UV-DDB/XPE is not homologous to any known yeast RAD protein, and it may be a factor restricted to higher eukaryotes (Takao et al., 1993) , Under some conditions, p127 has been found to copurify with a 41 kDa protein, and preparations containing these two proteins can correct the mild XP-E repair defect after microinjection into XP-E fibroblasts (Keeney et al., 1994) . The preparation of p127 UV-DDB used in the present experiments is very active in retardation of UV-irradiated DNA fragments, but contains little or no 41 kDa component (Figure 4) . Although UV-DDB/XPE factor can bind strongly to photoproducts in UV-damaged DNA, it binds much less well to other types of DNA damage (Abramic et al., 1991; Reardon et al., 1993; van Assendelft et al., 1993; Treiber et al., 1992; Feldberg and Grossman, 1976; Chu and Chang, 1988) . In contrast, the XPA protein has properties that make it a candidate for a part of the general DNA damage recognition system . The absence of XPA abolishes the excision repair ability, even in the presence of XPE factor, showing that XPA and XPE functions are not interchangeable. Perhaps UV-DDB/XPE factor has an auxiliary role in recognition, or in the catalytic turnover of the incision/excision complex, during repair of UV-irradiated DNA.
Repair DNA Synthesis by Purified Mammalian DNA Replication Factors
In addition to incision~excision proteins, the experiments here used the mammalian DNA replication proteins, RPA, PCNA, RFC, DNA pol s, and DNA ligase I. These factors could carry out gap-filling repair synthesis in either onestage or two-stage reactions. NER is known to utilize PCNA both in vitro (Shivji et al., 1992; Nichols and Sancar, 1992) and in vivo (Cells and Madsen, 1986; Miura et al., 1992) . RFC has been shown to load PCNA onto a repairtype template for synthesis by either DNA pol 8 or pol (Podust et al., 1994) . It is possible that either of these polymerases may function in the gap-filling step in vivo, but pol s appears to be most suited for filling of such short gaps in a PCNA-and RFC-dependent manner (Podust and H~bscher, 1993; Li et al., 1994 ; M. K. K. S., V. N. P., U. H., and R. D. W., unpublished data). DNA ligase I was used to seal the nick remaining after the gap filling and so to complete the repair reaction. Three DNA ligases are available in human cells, but ligase I is a good candidate for gap filling during NER, as mutations in the corresponding gene lead to UV sensitivity (Barnes et al., 1992) . There is scope for improvement of the ligation efficiency during the NER reconstitution reaction when all components are present. Addition of DNase IV did not alter the reaction with pol a, and we are currently seeking other factors that can improve the ligation efficiency.
Overall, the reaction described here is currently less efficient with purified components than with crude extracts. About 120 fmol of dAMP was incorporated into the partially fractionated system shown in Figure 3 , whereas 600 fmol of dAMP was incorporated into directly comparable reactions with whole-cell extracts (O'Donovan et al., 1994a (O'Donovan et al., , 1994b Shivji et al., 1994) . With the more purified components used in Figure 7 , the extent of repair was reduced by a further 2-fold below that in Figure 3 . Other auxiliary protein factors (as predicted from genetic studies) may be sought to improve the reaction efficiency.
The number of polypeptides in the full repair synthesis reaction seems remarkable and can be estimated by considering the twelve components of the reaction: XPA, XPG, TFIIH (six to nine polypeptides), XPC (two polypeptides), UV-DDB (one to two polypeptide8 when present), ERCC1/XPF complex (two known polypeptides), IF7 (at least one polypeptide), RPA (three subunits), PCNA (a homotrimer), RFC (five subunits), DNA pol s (two subunits), and DNA ligase I, a total of about 30 polypeptides. The repair reaction outlined here acts on so-called naked DNA substrates, and further proteins may be required to deal with the additional level of complexity conferred by the chromatin structure of genomic DNA. The delineation of the core factors now provides a basic framework for understanding the mechanism of their interactions with one another and with damaged DNA. This multitude of complex proteins involved in the cellular response to a major group of DNA-damaging agents reflects the prime importance of D NA repair processes in counteracting cytotoxicity, mutagenesis, and carcinogenesis.
Experimental Procedures HeLa Cell Extract Fractionation
A 20 liter culture of HeLa cells at 7.2 x 10 ~ cells per ml was washed in phosphate-buffered saline and collected to give a packed cell volume of 65 ml. A whole-cell extract was prepared as described (Shivji et al., 1992) After centrifugation at 10,000 rpm for 10 rain at 4°C, 40 ml of supernatant (600 mg of protein) was collected. Whole-cell extract was loaded onto a 70 ml column (2.5 cm x 15 cm) of phosphocellulose (Whatman P11) that been equilibrated in buffer A containing 0,1 M KCI. The flowthrough was collected at 20 ml/hr and used as fraction FI (344 mg). Proteins that bound to the column were sequentially eluted with buffer A containing 0.4, 0.6, and 1.0 M KCI to yield fractions FII (245 rag), Fill (12 rag), and FIV (12 rag), respectively. Of each fraction, 10 ml was concentrated and dialyzed against buffer A containing 0.1 M KCI and used for reconstitution reactions. Aliquots were frozen at -80°C.
Of fraction FII, 40 ml (200 mg of protein) was loaded onto a 2.5 cm x 4 cm hydroxyapatite column (Bio-Gel HT; Bio-Rad) equilibrated in buffer B (25 mM HEPES-KOH, 0.2 mM EDTA, 1 M KCI, 5% glycerol, 2.0 mM DTT, 0.1 mM PMSF) containing 1 mM phosphate (pH 6.8). The proteins were eluted from the column sequentially with buffer B containing 20, 60, 200, and 500 mM phosphate at 10 ml/hr. Fractions Ila (12 rag), lib (24 rag), IIc (3 rag), and lid (0.3 rag) were concentrated and dialyzed against buffer A containing 0.1 M KCI.
Proteins TFIIH was purified from HeLa cells by chromatography as described, through the final hydroxyapatite high pressure liquid chromatography (HPLC) step (Gerard et al., 1991; Schaeffer et al., 1993) . The fractions most active in transcription (50-100 ng of protein per p.I) were used. XPC protein complex was purified from -5 x 101° frozen HeLa cells exactly as described by Masutani et al. (1994) , and the final preparation contained two polypeptides migrating at 125 kDa and 58 kDa, respectively, on SDS-PAGE. UV-DDB was purified from monkey TC-7 cells as described (Abramic et al., 1991) .
His-tagged recombinant XPA protein was produced in E. coil and purified to homogeneity as described and had a concentration of 750 .p.g/ml. Recombinant XPG protein was produced in insect cells and purified to homogeneity as described (O'Donovan et al., 1994b) and had a concentration of 10 ~g/ml. RPA heterotrimer was purified from HeLa cells and from calf thymus according to published procedures (Kenny et al., 1989; Georgaki and H(~bscher, 1993) .
The dual-subunit DNA pol c, the multisubunit RFC, and PCNA for two-stage reactions were purified from calf thymus (Podust et al., 1992; Podust and H0bscher, 1993) . Their activities were determined in an assay using singly primed M13 DNA (Podust et al., 1992) . DNA ligase I from calf thymus was as described (Tomkinson et al., 1990) . DNase IV was purified from HeLa cells as described (Robins et al., 1994) . Exo-free DNA pol I was purchased from United States Biochemical as a recombinant product that lacked both 5'-3' and 3'-5' exonuclease activities.
Purification of ERCCl Complex from HeLa Cells A nuclear extract (Masutani et al., 1994 ) from -5 x 10 l° frozen HeLa cells was the starting material for ERCC1 complex purification. Phosphocellulose and single-stranded DNA cellulose chromatography were performed as described for purification of XPC (Masutani et al., 1994) . Of the 0.6 M KCI flowthrough fraction from the single-strand DNA cellulose column, 400 ml (600 mg of protein) was dialyzed against two changes of 2 liters of buffer C (25 mM HEPES-KOH [pH 7.8], 100/0 glycerol, 0.02°/0 NP-40, 2.0 mM D'IT, 0.2 mM AEBSF-HCI [Calbiochem] , 1 mM benzamidine [Sigma] , 10 i~g/ml leupeptin [Sigma], 1 p~g/ml pepstatin [Sigma]) containing 1 M KCI and 1 mM potassium phosphate and was loaded onto a 60 ml Bio-Gel HT hydroxyapatite column. ERCC1 was eluted in buffer C containing 60 mM potassium phosphate and 1 M KCI, precipitated with 0.44 g/ml (NH4)2SO4, and centrifuged, and the pellet was dialyzed for 5 hr in buffer C containing 1 M KCI and 1 mM EDTA. The dialyzed fraction (14 ml, 140 mg of protein) was loaded onto a 2.5 cm x 90 cm Ultrogel AcA34 column (IBF Biotechnics). The fractions containing ERCC1 detected by immunoblotting were checked for group 1 complementing repair activity, pooled (100 ml, 39 mg of protein), and dialyzed into buffer C containing 50 mM KCI and 1 mM EDTA. The retentate was loaded onto a 1 ml Fast Flow CM-Sepharose column (Pharmacia). Fractions were collected across a gradient of 50-300 mM KCI, and those containing ERCC1 detected by immunoblotting (fractions 19-30) were pooled and checked for group 1 complementing activity. Two ml (6 mg of protein) was diluted to 50 mM KCI in buffer C containing 1 mM EDTA and loaded onto an FPLC Mono Q HR 5/5 column (Pharmacia). The flowthrough from the Mono Q column (fractions 1-22,11 ml) was designated MFT. A gradient of 50-300 mM KCI in buffer 8 was applied and 0.5 ml fractions screened for the presence of ERCC1 polypeptide and group 1 complementing activity. Positive fractions (48, 49, and 50) were pooled, diluted to 50 mM KCI with buffer C, and loaded onto an FPLC Mono S HR 5/5 column (Pharmacia) in buffer B containing 50 mM KCl. Fractions (0.5 ml) were taken during elution of the column with a gradient from 80 to 220 mM KCI, and then ERCCl polypeptide (and group 1 complementing activity) was eluted with 300 mM KCI and collected in fractions 61 and 62.
Repair Synthesis
The plasmids used were the 3.0 kb pBiuescript KS(+) and the 3.7 kb priM14, pBluescript KS(+) was UV irradiated (450 Jim2). Both plasmids were treated with E. coli Nth protein, and closed circular DNA was isolated from cesium chloride and sucrose gradients . Reaction mixtures (50 p.I) contained 250 ng of irradiated pBluescript KS(+) and 250 ng of nonirradiated priM 14, 45 mM HEPES-KOH (pH 7.8), 70 mM KCI, 7.4 mM MgCI2, 0.9 mM D'IT, 0.4 mM EDTA, 20 p.M each of dGTP, dCTP, and l-rP, 8 ~M dATP, 74 kBq of [~x-32P]dATP (110 TBq/mmol), 2 mM ATP, 22 mM phosphocreatine (diTris salt), 2.5 I~g of creatine phosphokinase, 3.4% glycerol, 18 p.g of bovine serum albumin, and repair proteins or fractions as indicated. Reactions were incubated at 30°C for 3 hr or as specified. For assay of ERCC1 complex fractions, CFII fractions from the recipient cell lines were used in combination with human RPA and PCNA . Plasmid DNA was purified from the reaction mixtures, linearized (when appropriate), and separated by electrophoresis overnight on a t 0/0 agarose gel containing -0.3 I~g/ml ethidium bromide. Data were analyzed by autoradiographywith intensifying screens, densitometry, and liquid scintillation counting of the excised bands, taking into account the 1.6-fold greater fluorescence of nicked circular DNA over closed circular DNA.
Protein Blotting with ERCC1
Recombinant His-tagged ERCC1 was purified by Ni-NTA agarose chromatography and then by excision from an SDS-polyacrylamide gel and labeled with ~251 by use of Iodo-Gen reagent (Pierce) to a specific activity of 37.5 p, Ci/p,g ERCC1 (375 ~Ci/ ml). Protein samples to be analyzed were separated on minigels by SDS-PAGE and then transferred to an Immobilon P membrane (Millipore). The membrane was washed twice for 10 min with 50 ml of buffer D (20 mM HEPES-KOH [pH 7.7], 2.5 mM MgCI2, 1 mM EDTA, 0.05% NP-40, 0.1 M KCI, 1 mM DTT, 0.02% NAN3), and then blocked for 30 min with 50 ml of buffer D containing 5% dried milk and 0.4 M NaCI, and then 1 hr in buffer D containing 2% dried milk and 0.4 M NaCI. To the above buffer, 50 p.I of ~2SI-His-ERCC1 was added and was incubated overnight at room temperature with gentle mixing. The membrane was then washed five times for 10 rain with 50 ml of buffer D containing 2% dried milk and 0.4 M NaCI, air dried, and exposed to X-ray film. Immunoblotting for ERCC1 used the affinity-purified antibody against C-terminal peptide 2 as described .
